Evidence map›Paper›PMID 26202771›Full record

ArticleSocial science & medicine (1982)2015

Heroin-related overdose: The unexplored influences of markets, marketing and source-types in the United States.

Sarah G Mars, Jason N Fessel, Philippe Bourgois, Fernando Montero, George Karandinos, Daniel Ciccarone

Open access · greenAbstract read
In one paragraph

Article in Social science & medicine (1982), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
6.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Socioenvironmental disasters and the dialectics of overdose mortality.The International journal on drug policy · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. State-Level Prevalence and Associates of Opioid Dependence in the USA.International journal of environmental research and public health · 2022
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Sarah G MarsDepartment of Family and Community Medicine, University of California, San Francisco, MU337E Box 0900, 500 Parnassus Avenue, San Francisco, CA 94143-0900, USA. Electronic address: sarah.mars@ucsf.edu.
Jason N FesselDepartment of Anthropology, History and Social Medicine, University of California, San Francisco, 3333 California Street, Suite 485, San Francisco, CA 94143-0850, USA. Electronic address: Jason.Fessel@ucsf.edu.
Philippe BourgoisSchool of Arts and Sciences, School of Medicine, University of Pennsylvania, 415 Anthropology Museum, 3260 South Street, Philadelphia, PA 19104-6398, USA. Electronic address: bourgois@sas.upenn.edu.
Fernando MonteroSchool of Arts and Sciences, School of Medicine, University of Pennsylvania, 415 Anthropology Museum, 3260 South Street, Philadelphia, PA 19104-6398, USA. Electronic address: monterocas@gmail.com.
George KarandinosSchool of Arts and Sciences, School of Medicine, University of Pennsylvania, 415 Anthropology Museum, 3260 South Street, Philadelphia, PA 19104-6398, USA. Electronic address: gkarandinos@gmail.com.
Daniel CiccaroneDepartment of Family and Community Medicine, 500 Parnassus Avenue, MUE3, San Francisco, CA 94143, USA. Electronic address: Daniel.Ciccarone@ucsf.edu.
University of California, San Francisco · USUniversity of the Arts · USUniversity of Pennsylvania · US

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Ronald G Collman · 1999 to 2026
$78.6M
The Logics for HIV Risk among Street-Based Heroin InjectorsR01DA010164 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI BRANAS, CHARLES C. · 1996 to 2014
$4.9M
Heroin in TransitionR01DA037820 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CICCARONE, DANIEL H · 2015 to 2019
$3.7M
Education and Empowerment Intervention for HIV Prevention In and Out of JailR01DA027204 · NIDA · UNIVERSITY OF PENNSYLVANIA · PI DRAINE, JEFFREY · 2009 to 2013
$2.7M
A randomized trial of urban vacant lot stabilization and substance abuse outcomesR01AA020331 · NIAAA · UNIVERSITY OF PENNSYLVANIA · PI BRANAS, CHARLES C., POLSKY, DANIEL E · 2012 to 2015
$2.7M
Heroin Price, Purity and Outcomes StudyR01DA027599 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CICCARONE, DANIEL H · 2010 to 2014
$1.8M
Exploratory Research on Late Initiation of Drug InjectionR01DA027689 · NIDA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BLUTHENTHAL, RICKY N, KRAL, ALEXANDER H · 2010 to 2012
$1.7M
NIAAA NIH HHS AA020331NIAAA NIH HHS R01 AA020331NIAID NIH HHS P30 AI045008NIDA NIH HHS DA027204NIDA NIH HHS DA027689NIDA NIH HHS DA037820NIDA NIH HHS DA10164NIDA NIH HHS DA27599NIDA NIH HHS R01 DA010164NIDA NIH HHS R01 DA027204NIDA NIH HHS R01 DA027599NIDA NIH HHS R01 DA027689NIDA NIH HHS R01 DA037820
6 · The paper itself

Abstract

Heroin overdose, more accurately termed 'heroin-related overdose' due to the frequent involvement of other drugs, is the leading cause of mortality among regular heroin users. (Degenhardt et al., 2010) Heroin injectors are at greater risk of hospital admission for heroin-related overdose (HOD) in the eastern United States where Colombian-sourced powder heroin is sold than in the western US where black 'tar' heroin predominates. (Unick et al., 2014) This paper examines under-researched influences on HOD, both fatal and non-fatal, using data from a qualitative study of injecting drug users of black tar heroin in San Francisco and powder heroin in Philadelphia Data were collected through in-depth, semi-structured interviews carried out in 2012 that were conducted against a background of longer-term participant-observation, ethnographic studies of drug users and dealers in Philadelphia (2007-12) and of users in San Francisco (1994-2007, 2012). Our findings suggest three types of previously unconsidered influences on overdose risk that arise both from structural socio-economic factors and from the physical properties of the heroin source-types: 1) retail market structure including information flow between users; 2) marketing techniques such as branding, free samples and pricing and 3) differences in the physical characteristics of the two major heroin source forms and how they affect injecting techniques and vascular health. Although chosen for their contrasting source-forms, we found that the two cities have contrasting dominant models of drug retailing: San Francisco respondents tended to buy through private dealers and Philadelphia respondents frequented an open-air street market where heroin is branded and free samples are distributed, although each city included both types of drug sales. These market structures and marketing techniques shape the availability of information regarding heroin potency and its dissemination among users who tend to seek out the strongest heroin available on a given day. The physical characteristics of these two source-types, the way they are prepared for injecting and their effects on vein health also differ markedly. The purpose of this paper is to examine some of the unexplored factors that may lead to heroin-related overdose in the United States and to generate hypotheses for further study.

Indexed as

MarketingAnthropology, CulturalDrug OverdoseDrug UsersFemaleHeroinHeroin DependenceHumansMalePhiladelphiaQualitative ResearchSan FranciscoSubstance Abuse, IntravenousHeroinDrug marketsHeroinHeroin distributionHeroin marketingHeroin overdoseHeroin purityInjection drug useUSA

Identifiers

PMID26202771
PMCPMC4587985
OpenAlexW853398623

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.